DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Friedreich’s Ataxia Drugs Price Analysis and Strategies - 2016” report to their offering.
“Friedreich’s Ataxia Drugs Price Analysis and Strategies - 2016”
Tweet this
Friedreich’s Ataxia Drugs Price Analysis and Strategies 2016, provides drug pricing data and benchmarks in the global Friedreich’s Ataxia market.
The research answers the following questions:
What are the key drugs marketed for Friedreich’s Ataxia and their clinical attributes? How are they positioned in the Global Friedreich’s Ataxia market?
What are the unit prices and annual treatment cost for Friedreich’s Ataxia therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
What are the unmet needs in the global Friedreich’s Ataxia drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Friedreich’s Ataxia?
Read full article at http://www.businesswire.com/news/home/20161104005440/en/Friedreichs-Ataxia-Drugs-Price-Analysis-Strategies-Report